Showing results (281-290 of 7,535) with videos related to
Sort By:
Pageof 754
Molecular Pharmaceutics|August 8, 2006
Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugatesPradeep Tyagi, Rajkumar Banerjee, Soumitra Basu, et al.Molecular Pharmaceutics|August 8, 2006
JNK1 as a molecular target to limit cellular mortality under hypoxiaSeema Betigeri, Refika I Pakunlu, Yang Wang, et al.Molecular Pharmaceutics|August 8, 2006
Cytotoxicity of organic compounds against ovarian cancer cells: a quantitative structure-activity relationship studyRajeshwar P Verma, Corwin HanschMolecular Pharmaceutics|January 30, 2007
Coexpression of vascular endothelial growth factor and interleukin-1 receptor antagonist for improved human islet survival and functionXiangxu Jia, Kun Cheng, Ram I MahatoMolecular Pharmaceutics|January 5, 2026
Design and Evaluation of a 68Ga-Labeled Dimeric Cyclic Peptide as a Large-Volume Linker Strategy for Balancing Affinity and Retention in CXCR4-Targeted PET ImagingJingjing Yu, Xu Zhou, Yang Pei, et al.Molecular Pharmaceutics|April 9, 2008
Pharmaceutically active natural product synthesis and supply via plant cell culture technologyMartin E Kolewe, Vishal Gaurav, Susan C RobertsMolecular Pharmaceutics|October 10, 2009
Estradiol and progesterone-mediated regulation of P-gp in P-gp overexpressing cells (NCI-ADR-RES) and placental cells (JAR)Lisa D Coles, Insong J Lee, Pamela J Voulalas, et al.Molecular Pharmaceutics|April 4, 2025
Nanotherapeutic Formulations for the Delivery of Cancer AntiangiogenicsAmelia Ultimo, Ayushi Jain, Elisabet Gomez-Gonzalez, et al.Molecular Pharmaceutics|April 7, 2025
Preclinical Evaluation and First-in-Human Study of [68Ga]Ga-αvβ6-2: A Novel Dimeric Integrin αvβ6-Targeted PET Probe for Pancreatic Cancer ImagingXiao Pang, Yan Zhao, Xiaolin Chen, et al.Molecular Pharmaceutics|April 9, 2025
Beyond Correlation: Establishing Causality in Protein Corona Formation for NanomedicineArshia Rafieioskouei, Kenneth Rogale, Amir Ata Saei, et al.Pageof 754